Carregant...
Management of toxicity to isoform α-specific PI3K inhibitors
Alterations in the phosphoinositide 3-kinase (PI3K)/AKT pathway are frequently found in cancer and are especially common in breast cancer, where it is estimated that 70% of tumors have some type of genetic alteration that could lead to pathway hyperactivation. A variety of PI3K pathway inhibitors ha...
Guardat en:
| Publicat a: | Ann Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923786/ https://ncbi.nlm.nih.gov/pubmed/31626273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdz440 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|